Generic lenalidomide in the works

[Guest guest]

Natco first to file with USFDA for generic lenalidomide partnering with

Pharmaceuticals Inc., USA.

Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food

and Drug Administration (FDA) seeking approval to market its LENALIDOMIDE 5, 10,

15 and 25 mg products strengths. Natco's LENALIDOMIDE tablets are generic

versions of Celgene's Revlimid® Tablets.

Upon successful commercialization, and Natco will share net profits on

sales. will assume responsibility for ongoing regulatory, legal, and

commercial expenses related to Natco's LENALIDOMIDE product.

Source:http://www.natcopharma.co.in/usfda.html

Celgene filed the lawsuit on October 8, 2010 in the United States District Court

for the District of New Jersey seeking to prevent NATCO from commercializing its

product prior to the expiration of certain U.S. Patents.

http://www.natcopharma.co.in/celgene_sues_natco.html

~chris

CLL CANADA